URBN
58
6
CRM
47
2
KSS
34
6
BDX
54
7
UAL
54
-10
AMT
62
4
OI
37
4
BWA
61
11
NKE
40
4
JBHT
38
12
HAS
51
2
TRV
48
2
DGX
44
-4
EOG
41
4
LNC
40
-5
NSC
40
3
NVDA
59
3
BF.B
53
2
OMC
65
7
AIV
64
6
URBN
58
6
CRM
47
2
KSS
34
6
BDX
54
7
UAL
54
-10
AMT
62
4
OI
37
4
BWA
61
11
NKE
40
4
JBHT
38
12
HAS
51
2
TRV
48
2
DGX
44
-4
EOG
41
4
LNC
40
-5
NSC
40
3
NVDA
59
3
BF.B
53
2
OMC
65
7
AIV
64
6
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.
Buy
51

VRNA
Verona Pharma PLC

Last Price:
15.70
Seasonality Move:
-2.23%

7 Day Trial

ALL ACCESS PASS

$ 7

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

Verona Pharma PLC Price Quote

$15.70
-0.03 (-0.19%)
(Updated: May 3, 2024 at 12:55 PM ET)

Verona Pharma PLC Key Stats

Buy
51
Verona Pharma PLC (VRNA) is a Buy
Day range:
$15.20 - $15.90
52-week range:
$11.83 - $23.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.1%
Volume:
508.8K
Avg. volume:
411.4K
1-year change:
-24.59%
Market cap:
$1.3B
Revenue:
$0
EPS:
$-0.72

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

  • Did Verona Pharma PLC Stock Go Up Last Month?
    Verona Pharma PLC share price went down by -1.26% last month
  • Did VRNA's Share Price Rise Over The Last Year?
    VRNA share price fell by -24.59% over the past 1 year

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $271.8M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 3.10

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$50.2M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $92.9M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Verona Pharma PLC Return On Invested Capital

Data Unavailable

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Bicycle Therapeutics PLC (BCYC)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • NuCana PLC (NCNA)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Data Unavailable

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 86.52%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.67
Upside from Last Price: 114.03%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    84.8M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders